• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

More data needed to determine safety of probiotics and prebiotics

byCaitlyn HuiandDeepti Shroff Karhade
July 18, 2018
in Gastroenterology, Infectious Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Studies are often lacking or inadequate with respect to reporting adverse events (AEs) related to probiotics and prebiotics.

2. The majority of the studies in the trial did not give a specified definition for AEs or serious adverse events (SAEs).

Evidence Rating Level: 1 (Excellent)

Study Rundown: Prebiotics and probiotics are both currently used widely in different food products and other aspects of our daily lives. The authors of this study aimed to describe the incidence and severity of AEs related to probiotics, prebiotics, and synbiotics. Generally, they found that an increased amount of data is required to accurately assess safety of probiotics and prebiotics. This study had several limitations. Of note, only English-language studies were included in the criteria for study selection, which may have contributed to less data in the analysis or bias related to the language restriction. Further, it was noted that trials might have been insufficiently powered to adequately detect adverse events (AEs). Overall, the study indicates that greater data collection and results are necessary for appropriate assessment of probiotic and prebiotic safety.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Probiotics, their health benefits and applications for developing healthier foods: a review

RELATED REPORTS

Probiotic mitigates gut hypoperfusion-associated acute gastrointestinal injury in patients undergoing cardiopulmonary bypass

Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss

Probiotic supplementation may improve outcomes in patients with type 2 diabetes

In-Depth [systematic review]: The authors of this study conducted a systematic review to assess reporting of safety of probiotics, prebiotics, and synbiotics in publications of randomized controlled trials. A total of 384 trials were included in the study. Four reviewers independently evaluated the study characteristics and conducted data extraction. The authors found that out of all of the trials included in the study, 98% of them did not specifically define AEs or SAEs in the RCTs. Further, the majority of the studies evaluated safety of probiotics (n = 265, 69%), compared to prebiotics or synbiotics. The authors found that study reporting was frequently inadequate among RCTs, with 37% of the RCTs only using generic statements to report on AEs and SAEs.

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: medication safetyprobiotics
Previous Post

2 Minute Medicine Rewind July 16, 2018

Next Post

Abstinence from substance use among adolescents is increasing

RelatedReports

Parental nonmedical prescription opioid use linked to adolescent use
Cardiology

Probiotic mitigates gut hypoperfusion-associated acute gastrointestinal injury in patients undergoing cardiopulmonary bypass

May 19, 2025
Many new pediatric asthma cases attributable to obesity
Endocrinology

Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss

January 7, 2025
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Probiotic supplementation may improve outcomes in patients with type 2 diabetes

January 14, 2024
Probiotics improve colic, reduce GI disorders in infants
Gastroenterology

Impact of multispecies probiotic in preventing antibiotic-associated diarrhea unclear

September 26, 2022
Next Post
E-interventions linked to short-term reduction in alcohol consumption in college students

Abstinence from substance use among adolescents is increasing

Meeting families, demographic information affect child abuse work-up

ADHD modestly associated with higher frequency of digital media use among teens

Mental health parity law associated with financial protection for children

Mental health parity law associated with financial protection for children

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.